TRT for men: what the science says vs. what coaches sell

What did @coachdarianbates actually say?

Darian recommends starting testosterone cypionate or enanthate at 100-200mg per week, split into at least two injections, using shallow intramuscular technique. He ties starting dose to SHBG levels, suggesting lower SHBG warrants starting closer to 100mg and higher SHBG closer to 200mg. He also describes an early "honeymoon period" of one to two weeks, which he attributes to dopamine transmission and "antigen receptor" activation in the brain, and advises waiting 8-12 weeks before reviewing bloods and adjusting.

The framing is practical and experience-based, aimed at men considering TRT who don't know where to begin. That's not inherently problematic. But several specific mechanistic claims deserve scrutiny, and one term he uses is simply wrong in a way that matters clinically.

Does the science back this up?

On dosing ranges, yes, mostly. On the SHBG-guided dose logic, it's reasonable but oversimplified. On the "honeymoon period" mechanism, he's partially right but uses an incorrect term that changes the meaning significantly.

The standard starting range of 100-200mg per week for testosterone enanthate or cypionate in hypogonadal men is broadly consistent with clinical guidance. The Endocrine Society's 2018 clinical practice guidelines (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism) recommend initiating therapy to achieve mid-normal physiological testosterone levels, which in practice often falls within this range. Splitting doses to reduce peak-to-trough fluctuations is also well-supported.

The SHBG rationale has some logic behind it. Higher SHBG binds more testosterone, leaving less bioavailable, so patients with elevated SHBG may need higher total testosterone to achieve equivalent free testosterone. This is discussed in the literature, including Vermeulen et al. (1999, Journal of Clinical Endocrinology and Metabolism), though using SHBG alone to set a starting dose, without total and free testosterone context, is a simplification.

What did they get wrong (or right)?

The biggest factual error is calling androgen receptors "antigen receptors." These are completely different things. Antigen receptors are part of immune function. Androgen receptors are what testosterone actually binds to. Getting this wrong in a public health video isn't trivial.

His dopamine claim is partially supported. Testosterone does modulate dopaminergic activity. Research including work by Celec et al. (2015, Neuroscience and Biobehavioral Reviews) has examined testosterone's effects on dopamine pathways, showing some interaction. But describing a one-to-two week "euphoric" period as primarily dopamine-driven is speculative. The early symptom response is likely multifactorial and not well-characterized in controlled trials.

What he got right: the two-injection-per-week split is genuinely better practice than weekly dosing for most patients in terms of stability. Waiting 8-12 weeks before adjusting is also consistent with clinical guidance, since testosterone levels take time to stabilize. His acknowledgment that some people notice nothing, and that anxiety or irritability can emerge, is honest and not often said clearly in TRT content.

What should you actually know?

TRT decisions should not be based on a TikTok video, even a reasonably accurate one. The dosing range Darian cites is real, but the right dose for any individual depends on baseline labs, symptoms, body composition, and clinical judgment, not a single SHBG number.

Water retention, appetite changes, and nipple sensitivity are genuine early side effects. Nipple sensitivity in particular warrants monitoring for gynecomastia, which can develop if estradiol rises significantly. That's not mentioned here, and it matters. The 2018 Endocrine Society guidelines recommend monitoring hematocrit, estradiol, and PSA alongside testosterone levels during treatment.

The instruction to "trust the process" and avoid being reactive is reasonable advice against over-adjusting too early. But it should not mean ignoring symptoms that could indicate a real problem, such as high hematocrit, worsening mood, or cardiovascular changes. Anyone starting TRT should be doing so under medical supervision with regular blood monitoring, not following a coaching program as their primary guide.